Evidence map›Paper›PMID 36514175›Full record

ArticleSystematic reviews2022

Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis.

Serge Eyebe, Hugues C Nana-Djeunga, Magellan Guewo-Fokeng, Guy Sadeu Wafeu, Marius Zambou Vouking, Salomon Massoda, Christine D Evina, Aurelia Condomat Zoumabo, Pierre Ongolo-Zogo, Jean-Ralph Zahar

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Serge EyebeUMR 1137, Infection, Antimicrobiens, Modélisation, Evolution, Université Sorbonne Paris Nord, Paris, France. drsergeeyebe@netcourrier.com.ORCID 0000-0002-2586-6906
Hugues C Nana-DjeungaCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Magellan Guewo-FokengDepartment of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Guy Sadeu WafeuCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Marius Zambou VoukingCentre for Development of Best Practices in Health (CDBPH), Yaoundé, Cameroon.
Salomon MassodaMinistry of Public Health, Yaoundé, Cameroon.
Christine D EvinaCentre for Development of Best Practices in Health (CDBPH), Yaoundé, Cameroon.
Aurelia Condomat ZoumaboCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Pierre Ongolo-ZogoCentre for Development of Best Practices in Health (CDBPH), Yaoundé, Cameroon.
Jean-Ralph ZaharUMR 1137, Infection, Antimicrobiens, Modélisation, Evolution, Université Sorbonne Paris Nord, Paris, France.
Université de Yaoundé I · CMMinistry of Public Health · CMSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfection with resistant Pseudomonas aeruginosa (RPA) in the intensive care unit (ICU) is known to be either endogenous or exogenous or both, but the roles of each of these contamination routes are yet to be clarified. Data regarding prevalence, risk factors, and environmental factors associated with RPA in ICU are very scanty and even when they exist, they seem to be contradictory. So, there is a strong interest in understanding both individual and environmental factors associated with RPA infection. This systematic review aims to investigate individual and environmental factors associated with the colonization and infection with RPA in ICU. METHODOLOGY: MEDLINE (Pubmed), EMBASE (OVID), the Cochrane Library (Wiley), Web of Science, CINAHL (EBSCOHost), and LILACS (BIREME) will be searched from inception onwards. Grey literature will be identified through Google Scholar and Open Grey. Two reviewers will independently screen all citations, abstracts, and full-text articles. Potential conflicts will be resolved through discussion. Methodological quality including bias will be appraised using appropriate approaches. A narrative synthesis will describe the quality and content of the epidemiological evidence. Prevalence, odds ratio, relative risk, and hazard radio with their respective 95% confidence intervals will be calculated. A meta-analysis of data extracted from eligible studies with similar populations and RPA testing will be performed. The analysis will evaluate factors influencing the estimates. A random effect model will be used to summarize effect sizes. DISCUSSION: Two contrasting hypotheses on risk factors of acquisition, colonization, and infection of RPA are being debated, especially in a context where available data are scanty or exhibit high discrepancy. Indeed, most of the reviews have been focalized on hospitalized patients, and not in ICU, and few of them address the issue of environmental factors. To fill that gap, this review will combine both analyses of individual and environmental risk factors using prevalence studies in ICU and evaluation of different methodologies. These two hypotheses will be tested and challenged and could serve as a basis for a more in-depth study to fill the methodological gaps that will be identified as part of this current review. SYSTEMATIC REVIEW REGISTRATION: This protocol has been submitted to the Prospective Register of Systematic Reviews (PROSPERO) and the registration number attributed was CRD42021233832 of 07 March 2021.

Indexed as

Intensive Care UnitsPseudomonas aeruginosaHumansMeta-Analysis as TopicReview Literature as TopicRisk FactorsSystematic Reviews as TopicAntibiotic resistanceInfectionIntensive care unitmultidrug resistanceResistant Pseudomonas aeruginosaRisk factors

Identifiers

PMID36514175
PMCPMC9749282
OpenAlexW4311348005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.